Characterization of cis-acting sequences and trans-acting signals regulating early growth response 1 and c-fos promoters through the granulocyte-macrophage colony-stimulating factor receptor in BA/F3 cells

Blood. 1997 Feb 15;89(4):1197-206.

Abstract

Human granulocyte-macrophage colony-stimulating factor (hGM-CSF) activates a set of genes such as c-fos, jun, myc, and early growth response gene 1 (egr-1). Studies on BA/F3 cells that express hGM-CSF receptor (hGMR) showed that two different signaling pathways controlled by distinct regions within the beta subunit are involved in activation of c-fos/c-jun genes and in c-myc, respectively. However, the region(s) of the beta subunit responsible for activation of the egr-1 gene and other regulatory genes has not been identified. We describe here how egr-1 promoter is activated by hGMR through two regions of the beta subunit, with these regions being required for activation of the c-fos promoter. Coexpression of dominant negative (dn) Ras (N17ras) or dn JAK2 almost completely suppressed the activation of egr-1 and c-fos promoters. Deletion analysis of egr-1 promoter showed two cis-acting regions responsible for activation by hGM-CSF or mouse interleukin-3 (mIL-3), one between nucleotide positions (nt) -56 and -116, and the other between nt -235 and -480, which contains tandem repeats of the serum response element (SRE) sites. Similar experiments with the c-fos promoter showed that cis-acting regions containing the SRE/AP-1 sites is sufficient for activation by hGM-CSF. Based on these observations, we propose that signaling pathways activating egr-1 and c-fos promoters are controlled by SRE elements, either through the same or overlapping pathways that involve JAK2 and Ras.

Publication types

  • Comparative Study
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Animals
  • Binding Sites
  • Cell Line
  • DNA-Binding Proteins / biosynthesis
  • DNA-Binding Proteins / genetics*
  • Early Growth Response Protein 1
  • Enzyme Inhibitors / pharmacology
  • Gene Expression Regulation / drug effects*
  • Genes, fos*
  • Genes, ras
  • Genistein
  • Granulocyte-Macrophage Colony-Stimulating Factor / pharmacology*
  • Hematopoietic Stem Cells / drug effects*
  • Hematopoietic Stem Cells / physiology
  • Humans
  • Immediate-Early Proteins*
  • Interleukin-4 / pharmacology
  • Isoflavones / pharmacology
  • Janus Kinase 1
  • Janus Kinase 2
  • Mice
  • Promoter Regions, Genetic*
  • Protein-Tyrosine Kinases / physiology
  • Proto-Oncogene Proteins c-fos / biosynthesis
  • Proto-Oncogene Proteins p21(ras) / physiology
  • Proto-Oncogene Proteins*
  • Receptors, Granulocyte-Macrophage Colony-Stimulating Factor / chemistry
  • Receptors, Granulocyte-Macrophage Colony-Stimulating Factor / drug effects
  • Receptors, Granulocyte-Macrophage Colony-Stimulating Factor / physiology*
  • Recombinant Proteins / pharmacology
  • Signal Transduction / physiology*
  • Transcription Factors / biosynthesis
  • Transcription Factors / genetics*

Substances

  • DNA-Binding Proteins
  • EGR1 protein, human
  • Early Growth Response Protein 1
  • Egr1 protein, mouse
  • Enzyme Inhibitors
  • Immediate-Early Proteins
  • Isoflavones
  • Proto-Oncogene Proteins
  • Proto-Oncogene Proteins c-fos
  • Receptors, Granulocyte-Macrophage Colony-Stimulating Factor
  • Recombinant Proteins
  • Transcription Factors
  • Interleukin-4
  • Granulocyte-Macrophage Colony-Stimulating Factor
  • Genistein
  • Protein-Tyrosine Kinases
  • JAK1 protein, human
  • JAK2 protein, human
  • Jak1 protein, mouse
  • Jak2 protein, mouse
  • Janus Kinase 1
  • Janus Kinase 2
  • HRAS protein, human
  • Proto-Oncogene Proteins p21(ras)